MedPath

Imperial College Healthcare Nhs Trust

Imperial College Healthcare Nhs Trust logo
🇬🇧United Kingdom
Ownership
Private, Subsidiary
Established
1823-01-01
Employees
1K
Market Cap
-
Website
http://www.imperial.nhs.uk

Clinical Trials

98

Active:20
Completed:38

Trial Phases

5 Phases

Phase 1:8
Phase 2:4
Phase 3:1
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (67 trials with phase data)• Click on a phase to view related trials

Not Applicable
42 (62.7%)
Phase 4
12 (17.9%)
Phase 1
8 (11.9%)
Phase 2
4 (6.0%)
Phase 3
1 (1.5%)

Ovarian Cancer Radiomics Approach in CT Led Evaluation

Recruiting
Conditions
Ovarian Cancer
First Posted Date
2025-02-10
Last Posted Date
2025-06-27
Lead Sponsor
Imperial College Healthcare NHS Trust
Target Recruit Count
168
Registration Number
NCT06817174
Locations
🇬🇧

Imperial College NHS Healthcare Trust, London, United Kingdom

Cerebral Oxygen Saturation Monitoring During Optimum Cord Management in Preterm Infants

Recruiting
Conditions
Pre-Term
First Posted Date
2024-07-29
Last Posted Date
2024-07-29
Lead Sponsor
Imperial College Healthcare NHS Trust
Target Recruit Count
40
Registration Number
NCT06526091
Locations
🇬🇧

Imperial College Healthcare NHS Trust, London, United Kingdom

Pipelle® Under Ultrasound Guidance (PUG) to Investigate Post-menopausal Bleeding.

Not Applicable
Recruiting
Conditions
Endometrial Hyperplasia
Post-Menopausal Bleeding
Endometrial Cancer
First Posted Date
2024-07-15
Last Posted Date
2024-07-15
Lead Sponsor
Imperial College Healthcare NHS Trust
Target Recruit Count
92
Registration Number
NCT06501846
Locations
🇬🇧

Queen Charlotte's and Chelsea Hospital, Imperial College Healthcare Trust, London, United Kingdom

Delirium After Cardiac Surgery in Intensive Care Units

Not Applicable
Recruiting
Conditions
Post Operative Delirium
Cardiac Surgery
Intensive Care Unit Delirium
First Posted Date
2024-04-09
Last Posted Date
2024-04-11
Lead Sponsor
Imperial College Healthcare NHS Trust
Target Recruit Count
30
Registration Number
NCT06355570
Locations
🇬🇧

Imperial College Healthcare NHS Trust, London, United Kingdom

The Analysis of Fatigue on Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukaemia

Active, not recruiting
Conditions
Chronic Myeloid Leukemia, Chronic Phase
Fatigue
Chronic Myeloid Leukemia
Sleep Disturbance
First Posted Date
2024-01-31
Last Posted Date
2024-01-31
Lead Sponsor
Imperial College Healthcare NHS Trust
Target Recruit Count
50
Registration Number
NCT06233890
Locations
🇬🇧

Imperial NHS Healthcare Trust, London, United Kingdom

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 16
  • Next

News

SepTiC Trial Investigates Enhanced Treatment Strategies for Sepsis Patients

The SepTiC study aims to refine sepsis treatment by addressing key questions regarding rapid testing, fluid management, and immune system support.

© Copyright 2025. All Rights Reserved by MedPath